SLC26A7
gene geneOn this page
Also known as SUT2
Summary
SLC26A7 (solute carrier family 26 member 7, HGNC:14467) is a protein-coding gene on chromosome 8q21.3, encoding Anion exchange transporter (Q8TE54). Acts as an anion channel mediating the transport of chloride, sulfate and oxalate ions.
This gene is one member of a family of sulfate/anion transporter genes. Family members are well conserved in gene structure and protein length yet have markedly different tissue expression patterns. This gene has abundant and specific expression in the kidney. Alternatively spliced transcript variants that encode different isoforms have been described.
Source: NCBI Gene 115111 — RefSeq curated summary.
At a glance
- Gene–disease (curated): congenital hypothyroidism (Strong, GenCC)
- GWAS associations: 7
- Clinical variants (ClinVar): 123 total — 1 pathogenic, 3 likely-pathogenic
- MANE Select transcript:
NM_052832
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14467 |
| Approved symbol | SLC26A7 |
| Name | solute carrier family 26 member 7 |
| Location | 8q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SUT2 |
| Ensembl gene | ENSG00000147606 |
| Ensembl biotype | protein_coding |
| OMIM | 608479 |
| Entrez | 115111 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 12 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000276609, ENST00000309536, ENST00000517930, ENST00000520249, ENST00000520818, ENST00000522181, ENST00000522862, ENST00000523719, ENST00000617078, ENST00000617233, ENST00000906535, ENST00000906536, ENST00000906537, ENST00000906538, ENST00000953486
RefSeq mRNA: 4 — MANE Select: NM_052832
NM_001282356, NM_001282357, NM_052832, NM_134266
CCDS: CCDS6254, CCDS6255, CCDS75765
Canonical transcript exons
ENST00000276609 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000980846 | 91318216 | 91318380 |
| ENSE00000980847 | 91334295 | 91334447 |
| ENSE00001024587 | 91338150 | 91338232 |
| ENSE00001132098 | 91395062 | 91398155 |
| ENSE00001132377 | 91249539 | 91249844 |
| ENSE00001168806 | 91295531 | 91295703 |
| ENSE00001168817 | 91289136 | 91289246 |
| ENSE00001168826 | 91249319 | 91249413 |
| ENSE00003502811 | 91351810 | 91351887 |
| ENSE00003516800 | 91393936 | 91394039 |
| ENSE00003529147 | 91366580 | 91366717 |
| ENSE00003576472 | 91352901 | 91352996 |
| ENSE00003584482 | 91369785 | 91369833 |
| ENSE00003586528 | 91340404 | 91340551 |
| ENSE00003624362 | 91343353 | 91343466 |
| ENSE00003637954 | 91393797 | 91393851 |
| ENSE00003685311 | 91363472 | 91363538 |
| ENSE00003686143 | 91362353 | 91362459 |
| ENSE00003693973 | 91389338 | 91389438 |
Expression profiles
Bgee: expression breadth ubiquitous, 178 present calls, max score 98.89.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.5729 / max 1316.4689, expressed in 86 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 89736 | 2.5372 | 84 |
| 89735 | 0.0233 | 5 |
| 89737 | 0.0124 | 4 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| thyroid gland | UBERON:0002046 | 98.89 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 98.83 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 98.71 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.27 | gold quality |
| retina | UBERON:0000966 | 94.25 | gold quality |
| kidney epithelium | UBERON:0004819 | 93.62 | gold quality |
| renal medulla | UBERON:0000362 | 93.27 | gold quality |
| kidney | UBERON:0002113 | 87.51 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 86.88 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.82 | gold quality |
| cortex of kidney | UBERON:0001225 | 84.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.74 | silver quality |
| metanephros | UBERON:0000081 | 79.25 | gold quality |
| endometrium | UBERON:0001295 | 77.05 | gold quality |
| lymph node | UBERON:0000029 | 74.80 | gold quality |
| placenta | UBERON:0001987 | 71.46 | gold quality |
| ventricular zone | UBERON:0003053 | 70.18 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 69.34 | gold quality |
| body of stomach | UBERON:0001161 | 68.18 | gold quality |
| stomach | UBERON:0000945 | 67.80 | gold quality |
| ganglionic eminence | UBERON:0004023 | 63.97 | gold quality |
| embryo | UBERON:0000922 | 63.96 | gold quality |
| uterus | UBERON:0000995 | 63.53 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 63.08 | gold quality |
| calcaneal tendon | UBERON:0003701 | 62.61 | gold quality |
| gall bladder | UBERON:0002110 | 62.47 | gold quality |
| right coronary artery | UBERON:0001625 | 60.52 | gold quality |
| fundus of stomach | UBERON:0001160 | 60.32 | gold quality |
| rectum | UBERON:0001052 | 58.90 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 58.69 | silver quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-131882 | yes | 8089.07 |
| E-CURD-119 | yes | 6270.68 |
| E-CURD-135 | yes | 2892.66 |
| E-ANND-3 | yes | 5.84 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
177 targeting SLC26A7, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-33A-5P | 99.99 | 68.62 | 1055 |
| HSA-MIR-33B-5P | 99.99 | 68.58 | 1062 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4514 | 99.99 | 67.10 | 1870 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
Literature-anchored findings (GeneRIF, showing 8)
- the molecular cloning from human HEVEC of a 2.9-kb cDNA encoding SLC26A7, a novel member of the SLC26 (solute carrier 26) sulfate/anion exchanger family (PMID:11829495)
- In human kidney SLC26A6 and A7 have a distinct, partially overlapping expression in distal segments of nephrons. The distribution partly differs from that found previously in rodent kidneys. (PMID:15956810)
- The trafficking to the cell surface suggests novel functional upregulation of SLC26A7 in states that are associated with hypokalemia or increased medullary tonicity. (PMID:16524946)
- SLC26A7 mutations appear to be associated with thyroid dyshormonogenesis. (PMID:29546359)
- Study reports homozygous truncating mutations in SLC26A7 in 6 unrelated families with goitrous congenital hypothyroidism and shows that goitrous hypothyroidism also occurs in Slc26a7-null mice. (PMID:30333321)
- SLC26A7 constitutes the thiocyanate-selective anion conductance of the basolateral membrane of the retinal pigment epithelium. (PMID:32726161)
- Relationships between SLC26A7 expressions and extra-thyroid metastasis of papillary thyroid carcinoma. (PMID:34593695)
- Alterations in SLC4A2, SLC26A7 and SLC26A9 Drive Acid-Base Imbalance in Gastric Neuroendocrine Tumors and Uncover a Novel Mechanism for a Co-Occurring Polyautoimmune Scenario. (PMID:34944008)
Cross-species orthologs
10 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Slc26a7 | ENSMUSG00000040569 |
| rattus_norvegicus | Slc26a7 | ENSRNOG00000006096 |
| drosophila_melanogaster | Prestin | FBGN0036770 |
| caenorhabditis_elegans | WBGENE00010788 | |
| caenorhabditis_elegans | WBGENE00010789 | |
| caenorhabditis_elegans | WBGENE00012259 | |
| caenorhabditis_elegans | WBGENE00013963 | |
| caenorhabditis_elegans | WBGENE00017464 | |
| caenorhabditis_elegans | WBGENE00018283 | |
| caenorhabditis_elegans | sulp-6 | WBGENE00020914 |
Paralogs (9): SLC26A4 (ENSG00000091137), SLC26A3 (ENSG00000091138), SLC26A8 (ENSG00000112053), SLC26A1 (ENSG00000145217), SLC26A2 (ENSG00000155850), SLC26A5 (ENSG00000170615), SLC26A9 (ENSG00000174502), SLC26A11 (ENSG00000181045), SLC26A6 (ENSG00000225697)
Protein
Protein identifiers
Anion exchange transporter — Q8TE54 (reviewed: Q8TE54)
Alternative names: Solute carrier family 26 member 7
All UniProt accessions (5): Q8TE54, A0A087WZI7, E5RFH2, E5RGL8, H0YB61
UniProt curated annotations — full annotation on UniProt →
Function. Acts as an anion channel mediating the transport of chloride, sulfate and oxalate ions. Mediates the transport of bromide, iodide, nitrate, gluconate, thiocyanate and bicarbonate ions. Its permeability towards bicarbonate is weak and increases when pH is above 7. Mediates thiocyanate transport in retinal pigment epithelium cells. Mediates iodide transport in the thyroid gland, playing an important role in the synthesis of thyroid hormones and the maintenance of thyroid function. Although it is an anion channel, according to PubMed:12736153 and PubMed:32119864 it has been shown to exhibit chloride-bicarbonate exchanger activity.
Subcellular location. Cell membrane. Basolateral cell membrane. Recycling endosome membrane. Apical cell membrane. Lateral cell membrane.
Tissue specificity. Expressed in the thyroid gland (at protein level). Expressed in tonsillar high endothelial venule endothelial cells (HEVEC), placenta and in testis, expressed in a subgroup of basal cells in the epididymal ducts.
Disease relevance. Disease-causing variants in SLC26A7 have been found in patients with thyroid dyshormonogenesis and congenital goitrous hypothyroidism.
Activity regulation. Is active at both alkaline and acidic pH. Activity is inhibited by 4,4’-Di-isothiocyanatostilbene-2,2’-disulfonic acid (DIDS - an inhibitor of several anion channels and transporters).
Induction. Up-regulated by hyperosmolarity and down-regulated by acidic pH.
Similarity. Belongs to the SLC26A/SulP transporter (TC 2.A.53) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TE54-1 | 1, 1A, 1B | yes |
| Q8TE54-2 | 2, B |
RefSeq proteins (4): NP_001269285, NP_001269286, NP_439897, NP_599028 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001902 | SLC26A/SulP_fam | Family |
| IPR002645 | STAS_dom | Domain |
| IPR011547 | SLC26A/SulP_dom | Domain |
| IPR036513 | STAS_dom_sf | Homologous_superfamily |
Pfam: PF00916, PF01740
Catalyzed reactions (Rhea), 10 shown:
- hydrogencarbonate(in) = hydrogencarbonate(out) (RHEA:28695)
- chloride(in) = chloride(out) (RHEA:29823)
- nitrate(in) = nitrate(out) (RHEA:34923)
- sulfate(in) = sulfate(out) (RHEA:34983)
- iodide(out) = iodide(in) (RHEA:66324)
- hydrogencarbonate(in) + chloride(out) = hydrogencarbonate(out) + chloride(in) (RHEA:72363)
- thiocyanate(in) = thiocyanate(out) (RHEA:75347)
- bromide(in) = bromide(out) (RHEA:75383)
- D-gluconate(in) = D-gluconate(out) (RHEA:76139)
- oxalate(in) = oxalate(out) (RHEA:76199)
UniProt features (32 total): topological domain 11, transmembrane region 11, sequence variant 4, sequence conflict 2, chain 1, domain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9IKV | ELECTRON MICROSCOPY | 3.1 |
| 9IKX | ELECTRON MICROSCOPY | 3.2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TE54-F1 | 80.77 | 0.43 |
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-427601 | Inorganic anion exchange by SLC26 transporters |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-425393 | |
| R-HSA-425407 | SLC-mediated transmembrane transport |
MSigDB gene sets: 191 (showing top):
RNGTGGGC_UNKNOWN, GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS, GOBP_DIGESTION, GOBP_ACID_SECRETION, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_INORGANIC_ANION_TRANSPORT, GOBP_THYROID_HORMONE_METABOLIC_PROCESS, RACCACAR_AML_Q6, FOXO4_01, FOXO1_01, CHX10_01, GOBP_ORGANIC_ACID_TRANSPORT, NKX61_01, GOBP_CHLORIDE_TRANSPORT, MARTINEZ_RB1_TARGETS_DN
GO Biological Process (14): gastric acid secretion (GO:0001696), thyroid hormone generation (GO:0006590), monoatomic ion transport (GO:0006811), chloride transport (GO:0006821), bicarbonate transport (GO:0015701), iodide transport (GO:0015705), nitrate transmembrane transport (GO:0015706), oxalate transport (GO:0019532), gluconate transmembrane transport (GO:0035429), sulfate transmembrane transport (GO:1902358), chloride transmembrane transport (GO:1902476), monoatomic anion transport (GO:0006820), transmembrane transport (GO:0055085), carboxylic acid transmembrane transport (GO:1905039)
GO Molecular Function (7): chloride channel activity (GO:0005254), bicarbonate transmembrane transporter activity (GO:0015106), sulfate transmembrane transporter activity (GO:0015116), oxalate transmembrane transporter activity (GO:0019531), chloride:bicarbonate antiporter activity (GO:0140900), monoatomic anion channel activity (GO:0005253), antiporter activity (GO:0015297)
GO Cellular Component (8): cytoplasm (GO:0005737), endosome (GO:0005768), plasma membrane (GO:0005886), basolateral plasma membrane (GO:0016323), apical plasma membrane (GO:0016324), lateral plasma membrane (GO:0016328), recycling endosome membrane (GO:0055038), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| SLC-mediated transport of inorganic anions | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 3 |
| inorganic anion transport | 3 |
| transmembrane transport | 3 |
| cellular anatomical structure | 3 |
| monoatomic anion transport | 2 |
| chloride transmembrane transporter activity | 2 |
| plasma membrane region | 2 |
| digestive system process | 1 |
| acid secretion | 1 |
| thyroid hormone metabolic process | 1 |
| nitrate import | 1 |
| dicarboxylic acid transport | 1 |
| carbohydrate transmembrane transport | 1 |
| aldonate transmembrane transport | 1 |
| sulfur compound transport | 1 |
| chloride transport | 1 |
| monoatomic anion transmembrane transport | 1 |
| monoatomic ion transport | 1 |
| cellular process | 1 |
| carboxylic acid transport | 1 |
| monoatomic anion channel activity | 1 |
| bicarbonate transport | 1 |
| transmembrane transporter activity | 1 |
| sulfur compound transmembrane transporter activity | 1 |
| sulfate transmembrane transport | 1 |
| dicarboxylic acid transmembrane transporter activity | 1 |
| oxalate transport | 1 |
| solute:inorganic anion antiporter activity | 1 |
| bicarbonate:monoatomic anion antiporter activity | 1 |
| monoatomic ion channel activity | 1 |
| monoatomic anion transmembrane transporter activity | 1 |
| secondary active transmembrane transporter activity | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| basal plasma membrane | 1 |
| apical part of cell | 1 |
| plasma membrane | 1 |
Protein interactions and networks
STRING
1342 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC26A7 | IYD | Q6PHW0 | 659 |
| SLC26A7 | SLC4A8 | Q2Y0W8 | 614 |
| SLC26A7 | SLC4A2 | P04920 | 602 |
| SLC26A7 | SLC4A1 | P02730 | 592 |
| SLC26A7 | SLC5A5 | Q92911 | 572 |
| SLC26A7 | SLC4A9 | Q96Q91 | 570 |
| SLC26A7 | DUOXA2 | Q1HG44 | 559 |
| SLC26A7 | SLC4A4 | Q9Y6R1 | 543 |
| SLC26A7 | SLC4A3 | P48751 | 476 |
| SLC26A7 | SLC4A5 | Q9BY07 | 463 |
| SLC26A7 | TSHR | P16473 | 457 |
| SLC26A7 | OR5B12 | Q96R08 | 432 |
| SLC26A7 | DUOXA1 | Q1HG43 | 421 |
| SLC26A7 | SLC13A1 | Q9BZW2 | 409 |
| SLC26A7 | SLC4A10 | Q6U841 | 407 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC26A7 | TIMM17B | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (13): SLC26A7 (Positive Genetic), SLC26A7 (Cross-Linking-MS (XL-MS)), SLC26A7 (Cross-Linking-MS (XL-MS)), AMFR (Affinity Capture-MS), ATP1B3 (Affinity Capture-MS), BRD2 (Affinity Capture-MS), ELAC2 (Affinity Capture-MS), GOLM1 (Affinity Capture-MS), HERC2 (Affinity Capture-MS), NPTN (Affinity Capture-MS), ORMDL1 (Affinity Capture-MS), TIMM17B (Affinity Capture-MS), TMEM43 (Affinity Capture-MS)
ESM2 similar proteins: A4IIF2, A8J6J0, B0JZG0, D7PC76, E9Q3M5, G3X939, G5EBK1, O04722, O13134, O88343, P02730, P04919, P23562, P26433, P32847, P58743, P92946, Q02920, Q11180, Q21751, Q22682, Q28362, Q2Y0W8, Q32LP4, Q4R445, Q4U116, Q5DTL9, Q5RAL2, Q6RI88, Q6RVG2, Q6U841, Q7LBE3, Q80ZA5, Q8BU91, Q8JZR6, Q8R2Z3, Q8T5S1, Q8TE54, Q94225, Q99NH7
Diamond homologs: A0FKN5, A4IIF2, A8J6J0, D7PC76, O43511, O70531, P40879, P45380, P50443, P53391, P53392, P58735, P58743, Q5EBI0, Q5RAL2, Q62273, Q65AC2, Q69DJ1, Q7LBE3, Q7T2C4, Q8BU91, Q8CIW6, Q8GYH8, Q8HY59, Q8NG04, Q8R2Z3, Q8TE54, Q924C9, Q99NH7, Q9BEG8, Q9BXS9, Q9EPH0, Q9FY46, Q9GJY3, Q9H2B4, Q9JKQ2, Q9R154, Q9R155, Q9SAY1, Q9WVC8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
123 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 3 |
| Uncertain significance | 96 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (4)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2164580 | NM_052832.4(SLC26A7):c.1554dup (p.Phe519fs) | Pathogenic |
| 2138395 | NM_052832.4(SLC26A7):c.1026+1G>A | Likely pathogenic |
| 3778828 | NM_052832.4(SLC26A7):c.974C>A (p.Ala325Asp) | Likely pathogenic |
| 828176 | NM_052832.4(SLC26A7):c.1498C>T (p.Gln500Ter) | Likely pathogenic |
SpliceAI
4658 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:91249618:GAGAA:G | acceptor_gain | 1.0000 |
| 8:91318210:TCTTA:T | acceptor_loss | 1.0000 |
| 8:91318211:CTTAG:C | acceptor_loss | 1.0000 |
| 8:91318212:TTA:T | acceptor_loss | 1.0000 |
| 8:91318213:TAGGT:T | acceptor_loss | 1.0000 |
| 8:91318214:A:AG | acceptor_gain | 1.0000 |
| 8:91318214:AGGT:A | acceptor_gain | 1.0000 |
| 8:91318215:G:GA | acceptor_loss | 1.0000 |
| 8:91318215:G:GG | acceptor_gain | 1.0000 |
| 8:91318215:GGT:G | acceptor_gain | 1.0000 |
| 8:91318215:GGTG:G | acceptor_gain | 1.0000 |
| 8:91318376:TTTAT:T | donor_gain | 1.0000 |
| 8:91318377:TTAT:T | donor_gain | 1.0000 |
| 8:91318378:TAT:T | donor_gain | 1.0000 |
| 8:91318380:TGT:T | donor_loss | 1.0000 |
| 8:91318381:G:GA | donor_loss | 1.0000 |
| 8:91318381:G:GG | donor_gain | 1.0000 |
| 8:91318382:TGA:T | donor_loss | 1.0000 |
| 8:91318383:GAGT:G | donor_loss | 1.0000 |
| 8:91338134:A:AG | acceptor_gain | 1.0000 |
| 8:91338134:AAAT:A | acceptor_gain | 1.0000 |
| 8:91338135:A:G | acceptor_gain | 1.0000 |
| 8:91352899:A:AG | acceptor_gain | 1.0000 |
| 8:91352900:G:GG | acceptor_gain | 1.0000 |
| 8:91352900:GTGT:G | acceptor_gain | 1.0000 |
| 8:91363471:GA:G | acceptor_gain | 1.0000 |
| 8:91363471:GAGCA:G | acceptor_gain | 1.0000 |
| 8:91363537:GT:G | donor_gain | 1.0000 |
| 8:91363539:G:GG | donor_gain | 1.0000 |
| 8:91363544:T:G | donor_gain | 1.0000 |
AlphaMissense
4321 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:91352913:A:C | S411R | 0.994 |
| 8:91352915:C:A | S411R | 0.994 |
| 8:91352915:C:G | S411R | 0.994 |
| 8:91289144:T:C | F68L | 0.993 |
| 8:91289146:T:A | F68L | 0.993 |
| 8:91289146:T:G | F68L | 0.993 |
| 8:91318297:G:C | A187P | 0.993 |
| 8:91318291:G:T | G185W | 0.992 |
| 8:91318292:G:A | G185E | 0.992 |
| 8:91318298:C:A | A187D | 0.992 |
| 8:91318280:C:A | A181E | 0.991 |
| 8:91334361:A:C | S237R | 0.991 |
| 8:91334363:C:A | S237R | 0.991 |
| 8:91334363:C:G | S237R | 0.991 |
| 8:91289148:C:A | A69D | 0.988 |
| 8:91289178:G:A | G79D | 0.988 |
| 8:91249812:G:A | G54E | 0.986 |
| 8:91249844:G:A | G65R | 0.986 |
| 8:91249844:G:C | G65R | 0.986 |
| 8:91343369:G:A | G348D | 0.986 |
| 8:91362359:T:A | W441R | 0.986 |
| 8:91362359:T:C | W441R | 0.986 |
| 8:91295693:G:A | G156D | 0.985 |
| 8:91318291:G:A | G185R | 0.984 |
| 8:91318291:G:C | G185R | 0.984 |
| 8:91352932:T:C | L417P | 0.984 |
| 8:91295540:C:A | A105D | 0.983 |
| 8:91289147:G:C | A69P | 0.982 |
| 8:91289177:G:C | G79R | 0.982 |
| 8:91295692:G:C | G156R | 0.982 |
dbSNP variants (sampled 300 via entrez): RS1000042955 (8:91313382 C>T), RS1000074172 (8:91313022 T>C), RS1000096778 (8:91214661 T>C), RS1000101050 (8:91322995 T>G), RS1000105490 (8:91356943 A>G), RS1000144351 (8:91222858 T>C,G), RS1000165082 (8:91252790 T>C), RS1000173935 (8:91363820 C>G), RS1000196011 (8:91339682 G>C), RS1000205881 (8:91278994 A>G), RS1000222013 (8:91319207 C>A,G), RS1000231313 (8:91241814 A>G), RS1000232508 (8:91382512 A>C,T), RS1000233689 (8:91257064 C>T), RS1000248620 (8:91331480 A>G)
Disease associations
OMIM: gene MIM:608479 | disease phenotypes:
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| congenital hypothyroidism | Strong | Autosomal recessive |
Mondo (1): congenital hypothyroidism (MONDO:0018612)
Orphanet (1): Congenital hypothyroidism (Orphanet:442)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001343_11 | Fat distribution (HIV) | 2.000000e-06 |
| GCST001343_16 | Fat distribution (HIV) | 8.000000e-06 |
| GCST001343_17 | Fat distribution (HIV) | 1.000000e-06 |
| GCST003542_6 | Night sleep phenotypes | 7.000000e-07 |
| GCST003542_7 | Night sleep phenotypes | 1.000000e-06 |
| GCST007269_278 | Pulse pressure | 3.000000e-13 |
| GCST011703_89 | Smoking initiation | 3.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004341 | body fat distribution |
| EFO:0005763 | pulse pressure measurement |
| EFO:0005670 | smoking initiation |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D003409 | Congenital Hypothyroidism | C05.116.099.343.347; C05.116.132.256; C16.320.240.625; C19.297.155; C19.874.482.281 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Anion channels
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Estradiol | decreases expression | 2 |
| Nickel | decreases expression | 2 |
| Aflatoxin B1 | decreases methylation, increases expression | 2 |
| bisphenol A | increases expression | 1 |
| cinnamaldehyde | increases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| perfluorohexanesulfonic acid | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Benzo(a)pyrene | increases mutagenesis | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | affects expression | 1 |
| 8-Bromo Cyclic Adenosine Monophosphate | increases expression | 1 |
| Asbestos, Serpentine | decreases methylation | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Genistein | decreases expression | 1 |
Clinical trials (associated diseases)
24 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT05228184 | PHASE4 | TERMINATED | Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH) |
| NCT05371262 | PHASE4 | COMPLETED | Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism |
| NCT00403390 | Not specified | COMPLETED | Generic vs. Name-Brand Levothyroxine |
| NCT00493103 | Not specified | COMPLETED | TG Gene Mutations and Congenital Hypothyroidism |
| NCT00497575 | Not specified | COMPLETED | Diagnosis and Follow-up of Patients With Subclinical Hypothyroidism |
| NCT00505479 | Not specified | UNKNOWN | Iodine Status in Pregnant Women and Their Newborns: is Congenital Hypothyroidism Related to Iodine Deficiency in Pregnancy? |
| NCT01223638 | Not specified | WITHDRAWN | The Prevalence of Hearing Loss Among Children With Congenital Hypothyroidism |
| NCT01349634 | Not specified | COMPLETED | The Effects of Iodized Salt on Cognitive Development in Ethiopia |
| NCT01488721 | Not specified | COMPLETED | Clinical Evaluation of NeoPlex4 Assay and NeoPlex System |
| NCT01916018 | Not specified | COMPLETED | Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. |
| NCT02307175 | Not specified | COMPLETED | A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication |
| NCT02374593 | Not specified | COMPLETED | Targeted Levothyroxine Dosing in Infants With Congenital Hypothyroidism |
| NCT03655223 | Not specified | ENROLLING_BY_INVITATION | Early Check: Expanded Screening in Newborns |
| NCT04712760 | Not specified | UNKNOWN | Congenital Hypothyroidism in Children With Eutopic Gland or Thyroid Hemiagenesis: Predictive Factors for Transient vs Permanent Hypothyroidism. |
| NCT04734457 | Not specified | UNKNOWN | Final Height in Patients With CH Diagnosed by the Screening |
| NCT05687474 | Not specified | COMPLETED | Baby Detect : Genomic Newborn Screening |
| NCT06724224 | Not specified | RECRUITING | Comparison of Levothyroxine Formulations in the Treatment of Congenital Hypothyroidism |
| NCT06728735 | Not specified | RECRUITING | Role of Next Generation Sequencing in the Etiological Diagnosis of Permanent Congenital Hypothyroidism With in Situ Thyroid |
| NCT06864039 | Not specified | ENROLLING_BY_INVITATION | Quality of Life and Long-term Outcome of Adequately Treated Congenital Hypothyroidism |
| NCT06864351 | Not specified | RECRUITING | Prospective Evaluation of OptiThyDose |
| NCT07126353 | Not specified | NOT_YET_RECRUITING | Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism |
| NCT07280104 | Not specified | RECRUITING | Infants With Primary Congenital Hypothyroidism and Development |
| NCT07425028 | Not specified | NOT_YET_RECRUITING | Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns |
| NCT07579988 | Not specified | NOT_YET_RECRUITING | Ultrasound Measurement of Thyroid Volume in Term Newborns |
Related Atlas pages
- Associated diseases: congenital hypothyroidism
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital hypothyroidism